6
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      Are you tired of sifting through news that doesn't interest you?
      Personalize your Karger newsletter today and get only the news that matters to you!

      Sign up

      • Record: found
      • Abstract: found
      • Article: found

      Human Connective Tissue Growth Factor mRNA Expression of Epiretinal and Subretinal Fibrovascular Membranes: A Report of Three Cases

      case-report

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose: To investigate the correlation between connective tissue growth factor (CTGF) mRNA expression and immunohistochemical characteristics (expression of type I collagen and tenascin) of fibrovascular membranes of proliferative retinal diseases under in vivo conditions. Methods: CTGF mRNA expression was investigated using in situ hybridization. Expression of type I collagen and tenascin was detected by immunohistochemical staining. Results: CTGF mRNA is produced in transformed retinal pigment epithelial cells and appears also in fibroblast-like cells, which are embedded in epiretinal and subretinal membranes of proliferative retinal diseases as well as in surgically removed subretinal membranes. In all examined membranes, expression of human CTGF mRNA appears in concurrence with the expression of type I collagen and tenascin. Conclusions: The predominant expression of CTGF mRNA in the development of fibrovascular membranes of proliferative retinal diseases suggests a significant role of CTGF in the pathological course of these ocular disorders.

          Related collections

          Most cited references3

          • Record: found
          • Abstract: not found
          • Article: not found

          Structurally distinct collagen types.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Growth factors in retinal diseases: Proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Regulation of connective tissue growth factor gene expression in retinal vascular endothelial cells by angiogenic growth factors

                Bookmark

                Author and article information

                Journal
                OPH
                Ophthalmologica
                10.1159/issn.0030-3755
                Ophthalmologica
                S. Karger AG
                0030-3755
                1423-0267
                2002
                August 2002
                29 August 2002
                : 216
                : 4
                : 284-291
                Affiliations
                University Eye Clinic, Basel, Switzerland
                Article
                63843 Ophthalmologica 2002;216:284–291
                10.1159/000063843
                12207135
                b3364679-7127-4d29-9809-5960b6dec661
                © 2002 S. Karger AG, Basel

                Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

                History
                : 17 July 2001
                : 14 December 2001
                Page count
                Figures: 3, References: 19, Pages: 8
                Categories
                Case Report · Description de cas · Fallbericht

                Vision sciences,Ophthalmology & Optometry,Pathology
                Connective tissue growth factor,Epiretinal membrane,Subretinal membrane,Proliferative retinal disease

                Comments

                Comment on this article